Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria.

Livermore DM, Mushtaq S, Warner M, Woodford N.

J Antimicrob Chemother. 2014 Apr;69(4):1050-6. doi: 10.1093/jac/dkt455. Epub 2013 Nov 19.

3.

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.

Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8.

PMID:
16105565
4.

[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].

Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL.

Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2753-8. Chinese.

PMID:
18167265
5.
6.
7.

Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters.

Mushtaq S, Warner M, Livermore D.

J Antimicrob Chemother. 2010 Feb;65(2):266-70. doi: 10.1093/jac/dkp425. Epub 2009 Dec 8.

8.

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ; Canadian Antimicrobial Resistance Alliance.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):67-80. doi: 10.1016/j.diagmicrobio.2008.04.012. Epub 2008 May 29.

PMID:
18513913
9.

['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].

Vay CA, Almuzara MN, Rodríguez CH, Pugliese ML, Lorenzo Barba F, Mattera JC, Famiglietti AM.

Rev Argent Microbiol. 2005 Jan-Mar;37(1):34-45. Spanish.

PMID:
15991478
10.

Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia.

Memish ZA, Shibl AM, Kambal AM, Ohaly YA, Ishaq A, Livermore DM.

J Antimicrob Chemother. 2012 Jul;67(7):1701-5. doi: 10.1093/jac/dks091. Epub 2012 Mar 29.

11.

Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.

Piéboji JG, Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P.

Int J Infect Dis. 2004 May;8(3):147-54.

14.

In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.

Rizek C, Ferraz JR, van der Heijden IM, Giudice M, Mostachio AK, Paez J, Carrilho C, Levin AS, Costa SF.

J Infect Chemother. 2015 Feb;21(2):114-7. doi: 10.1016/j.jiac.2014.10.009. Epub 2014 Nov 13.

PMID:
25456893
15.

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J; Canadian Antimicrobial Resistance Alliance (CARA), Hoban DJ.

Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19.

16.

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.

Fass RJ, Prior RB.

Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74.

17.
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk